SCHEMBL6021776

SCHEMBL6021776

CCCCCCN(Cc1ccc(Br)o1)C1CCN([S+]([O-])c2ccc(CNC(=O)c3ccc(Cl)cc3)s2)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
DRD2 P14416 5/20 0.32
DRD3 P35462 5/20 0.32
DRD4 P21917 3/20 0.32
NR1D1 P20393 2/20 0.32
NR1H3 Q13133 1/20 0.32
NR1D2 Q14995 1/20 0.32
LMNA P02545 2/20 0.31
GAA P10253 1/20 0.31
MAPK1 P28482 1/20 0.31
BCL2 P10415 1/20 0.31
TP53 P04637 1/20 0.31
ALDH1A1 P00352 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
HPGD P15428 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139807 0.89 DRD2 (0.38) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL6022189 0.86 CYP3A4 (0.36) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL3480029 0.84 MAPK9 (0.50) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL7146894 0.84 TMEM97 (0.40) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL6021656 0.84 DRD2 (0.39) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL7142563 0.72 TP53 (0.44) LMNATP53ALDH1A1SMN1; SMN2KDM4E
SCHEMBL7139566 0.72 KDM4E (0.42) MAPK9MAPK10GAAALDH1A1SMN1; SMN2
SCHEMBL3479709 0.72 MAPK9 (0.54) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL3480006 0.71 MAPK9 (0.55) MAPK9MAPK10DRD2DRD3DRD4
SCHEMBL3480185 0.71 MAPK9 (0.51) MAPK9MAPK10DRD2DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 EP claimed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO claimed